← All trials
NCT04701346
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2021
- Primary completion
- Aug 31, 2023
- Completion date
- Aug 31, 2023
- First posted
- Jan 8, 2021
- Last posted
- Apr 13, 2021
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of OsloLead sponsor
- Charles UniversityCollaborator
- University of OxfordCollaborator
- Maastricht UniversityCollaborator
- University of OsloReponsible party - principal investigator
- University of OsloStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.